Biggest News Aggregation in the World
📰 Jonathan Graham News

Page 2 - Jonathan Graham News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Jonathan Graham. Real-time updates on events, politics, business and more.

Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors

Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric and adult patients Gastroenteropancreatic neuroendocrine...
United States Baja California Michael Meo Tina Deignan Theodore Laetsch Isabella Zinck

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting

V-INITIATE trial demonstrates that early initiation with Leqvio, prior to guideline-recommended ezetimibe, for ASCVD patients unable to achieve LDL-C goal on statin therapy alone led to significant LDL-C reduction vs. clinician-determined usual care (60% vs. 7% respectively)1 A significantly greater proportion of the ASCVD patients receiving Leqvio achieved guideline-recommended LDL-C goal vs. the usual care arm […]
United States South Korea Noord Holland Michael Meo Marlena Abdinoor Michael Koren

New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting

V-INITIATE trial demonstrates that early initiation with Leqvio, prior to guideline-recommended ezetimibe, for ASCVD patients unable to achieve LDL-C goal on...
South Korea Noord Holland United States Michael Koren Sloan Simpson Prnewswire Novartis

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science